BackEnanta Pharmaceuticals Overview

Enanta Pharmaceuticals Total Revenue

Revenue analysis for ENTA.

Quarterly Revenue

$17.16M
14.96% YoY

As of Mar 2026

Annual Revenue (TTM)

$69.21M
7.37% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading